Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04665245 · ClinicalTrials.gov registry record
Symptom-Based Markers for COVID-19 Transmission
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 214
- Enrollment target
NCT04665245 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 214 participants.
The verdict
NCT04665245 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 214 participants
- Enrollment target
Study Summary
In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at different points of the day. This study will be a single cohort, observational study of COVID-19 patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2021-05-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04665245
The ClinicalTrials.gov registry entry for NCT04665245 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04665245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04665245 about?
NCT04665245 is a clinical study titled "Symptom-Based Markers for COVID-19 Transmission". In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at...
What is the current status of trial NCT04665245?
This trial is currently completed. The enrollment target is 214 participants. The study started on 2020-12-15. Estimated completion is 2021-05-19.
Who is sponsoring clinical trial NCT04665245?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.